结构修饰的基衍生物的药物动力学相关性是治疗结核病的有希望的途径
Sarvesh Sabarathinam1,2,3, Nila Ganamurali3, Sanjana Satheesh4
1Drug Testing Laboratory, Interdisciplinary Institute of Indian System of Medicine, SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.
这项研究使用了计算机辅助药物设计来评估改性石作为潜在的抗结核剂. 根据药物相似性和药理动力学特性确定了有前途的化合物,以便在未来开发.
科学领域:
- 药用化学 医学化学
- 计算机化药物设计技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,需要新的治疗策略.
- 从黄酸盐中衍生出来的哈尔科因因其多样化的生物活动而闻名.
- 有效的药物开发需要早期识别具有有利的药物类似性和药物动力学特征的化合物.
研究的目的:
- 为了评估结构修饰的石灰衍生物作为潜在的抗结核剂.
- 识别具有高治疗潜力的化合物,用于对抗Mycobacterium tuberculosis H37Rv.
- 为了评估所选石的药物相似性和药理动力学特性.
主要方法:
- 计算机辅助药物设计被用来选和选择石灰衍生物.
- 通过文献搜索,发现了14种有前途的结构修饰型石英.
- 评估了对Mycobacterium结核病H37Rv标的抑制活性.
主要成果:
- 选择的石墨烯衍生物显示出作为抗结核病剂的潜力.
- 药物相似性和药物动力学特性是评估治疗潜力的关键标准.
- 该研究确定了用于进一步研究抗结核药物开发的分子.
结论:
- 结构修饰的石具有作为新型抗肺结核药物候选人的前景.
- 计算药物设计和药理动力学分析对于早期抗结核病药物发现至关重要.
- 对这些石的进一步研究可能会导致结核病的新疗法.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
相关概念视频
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
